The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome.
about
Treatment of primary Sjögren syndrome.High-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren's Syndrome: Data from the TEARS Randomized Trial.Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.Rituximab in primary Sjögren's syndrome: a ten-year journey.Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED).Biologic treatment in Sjögren's syndrome.Renal involvement in primary Sjögren's syndrome.Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome.
P2860
Q30249011-EE46614A-2254-457F-B920-EF6A35B70505Q30372606-63B078BD-6A9E-43D4-8194-B5834A2BEB0FQ30948155-3B05BFF9-5985-4673-8473-AD6177DEBDCEQ34432465-A0C034D1-C269-40DD-B7A9-04CBAE3827A7Q35774612-62B53777-278B-4DF6-9069-EA38FA1187E4Q35805082-67CB1AEC-62A6-44EE-BC4E-0EA8993AAC44Q38262453-820FAD13-C88D-401D-8ED6-3919E95A8613Q38526786-7E46D1DD-1C27-4739-ADE3-00DA4E28AC0EQ38676903-1F502B83-F60D-4CBB-9A50-8F80E6EC254AQ38906337-BF63236B-1C1F-4E6E-841D-3A30E1DB04EBQ40117123-9A435600-3E0F-47CE-AA58-B9D1C9EDE7FFQ40383414-2BA9C5D0-3D0B-47CB-825C-7FDE94D26E16Q47133516-D8410A32-F348-45A0-8C67-512041A66AEB
P2860
The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@en
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@en-gb
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@nl
type
label
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@en
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@en-gb
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@nl
prefLabel
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@en
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@en-gb
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@nl
P2093
P2860
P50
P356
P1154
2-s2.0-84896711661
P1476
The TRACTISS protocol: a rando ...... th primary Sjögren's Syndrome.
@en
P2093
Ana Poveda-Gallego
Catherine Reynolds
Clodagh Woods
Colin Everett
Colin Pease
Elizabeth Price
Emma Skinner
Frances Hall
Iain Macleod
Janine Gray
P2860
P2888
P356
10.1186/1471-2474-15-21
P5530
P577
2014-01-17T00:00:00Z
P5875
P6179
1041359232